Stocks

Brainstorm Cell Therapeutics BCLI

Health care sectorOTC markets

Company

Exchange
OTC markets
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
New York, New York
Fiscal year end
12/31
Next earnings
11/13, estimated

5% stakes

Holder
Armistice Capital25/05/159.99%717,500 sh+5.0pp
All 5% stake reports on Brainstorm Cell Therapeutics

26-week trading